Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
Makito Miyake(Nara Medical University), Charles J. Rosser(Nonagen Bioscience (United States))
Cited by 48
Related Papers
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways
|Laboratory Investigation|2013|146
A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
|PLoS ONE|2012|108